1. Home
  2. Publications
  3. Publications of type "Paper"

Publications of type "Paper"

Enter any text in the title of the paper (e.g. 'Breast'; 'Scotland')
The full UKIACR member associated with this publication

  1. A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study.

    Holmberg L, Robinson D, Sandin F, Bray F, Linklater KM, Klint A, Lambert PC, Adolfsson J, Hamdy FC, Catto J, Møller H
    Cancer Epidemiol. 2012 Feb; 36(1):e7-12. PMID: 21907655

  2. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.

    Lake J, Mak V, Møller H, Davies EA
    Public Health. 2012 Jan; 126(1):57-63. PMID: 22153886

  3. Improvements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management?

    Crawford R, Greenberg D
    BJOG. 2012 Jan; 119(2):160-5. PMID: 21481154

  4. Cancer at ages 15-29 years: the contrasting incidence in India and England.

    Arora RS, Alston RD, Eden TO, Moran A, Geraci M, O'Hara C, Birch JM
    Pediatr Blood Cancer. 2012 Jan; 58(1):55-60. PMID: 20949596

  5. Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis.

    Møller H, Sandin F, Robinson D, Bray F, Klint S, Linklater KM, Lambert PC, Påhlman L, Holmberg L, Morris E
    Eur J Cancer. 2012 Jan; 48(1):46-53. PMID: 21676610

  6. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006.

    Riaz SP, Lüchtenborg M, Jack RH, Coupland VH, Linklater KM, Peake MD, Møller H
    Eur J Cancer. 2012 Jan; 48(1):54-60. PMID: 21871792

  7. Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.

    Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA
    BMC Cancer. 2012 Jan 12; 12:11. PMID: 22239958

  8. Risk profiles of prostate cancers identified from UK primary care using national referral guidelines.

    Serag H, Banerjee S, Saeb-Parsy K, Irving S, Wright K, Stearn S, Doble A, Gnanapragasam VJ
    Br J Cancer. 2012 Jan 31; 106(3):436-9. PMID: 22240787

  9. Quantifying differences in breast cancer survival between England and Norway.

    Lambert PC, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, Robinson D, Møller H
    Cancer Epidemiol. 2011 Dec; 35(6):526-33. PMID: 21606014

  10. The cancer burden in the United Kingdom in 2007 due to radiotherapy.

    Maddams J, Parkin DM, Darby SC
    Int J Cancer. 2011 Dec 15; 129(12):2885-93. PMID: 21671469

  11. Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively.

    Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, Forman D, Gissler M, Katalinic A, Luostarinen T, Pukkala E, Rahu M, Storm H, Sund R, Törnberg S, Tryggvadottir L
    Eur J Public Health. 2011 Dec; 21(6):686-7. PMID: 22080476

  12. Factors affecting the use of patient survey data for quality improvement in the Veterans Health Administration.

    Davies EA, Meterko MM, Charns MP, Seibert ME, Cleary PD
    BMC Health Serv Res. 2011 Dec 12; 11:334. PMID: 22151714

  13. Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization.

    Riaz SP, Horton M, Kang J, Mak V, Lüchtenborg M, Møller H
    J Thorac Oncol. 2011 Dec; 6(12):2005-10. PMID: 21892107

  14. Malignant melanoma and breast carcinoma: a bidirectional correlation.

    Ho WL, Comber H, Hill AD, Murphy GM
    Ir J Med Sci. 2011 Dec; 180(4):901-3. PMID: 19263184

  15. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis.

    Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L, Rota M, Corrao G, Garavello W, Schüz J, Straif K, Negri E, Boffetta P, La Vecchia C
    Int J Cancer. 2011 Nov 15; 129(10):2473-84. PMID: 21190191

  16. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.

    Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M
    Breast Cancer Res Treat. 2011 Nov; 130(2):609-18. PMID: 21671018

  17. A person-time analysis of hospital activity among cancer survivors in England.

    Maddams J, Utley M, Møller H
    Br J Cancer. 2011 Nov 8; 105 Suppl 1:S38-45. PMID: 22048031

  18. Hospital volume and survival in oesophagectomy and gastrectomy for cancer.

    Anderson O, Ni Z, Møller H, Coupland VH, Davies EA, Allum WH, Hanna GB
    Eur J Cancer. 2011 Nov; 47(16):2408-14. PMID: 21835609

  19. Predictors of early death in female patients with breast cancer in the UK: a cohort study.

    Stapelkamp C, Holmberg L, Tataru D, Møller H, Robinson D
    BMJ Open. 2011; 1(2):e000247. PMID: 22123920

  20. Integrating cancer survivors' experiences into UK cancer registries: design and development of the ePOCS system (electronic Patient-reported Outcomes from Cancer Survivors).

    Ashley L, Jones H, Thomas J, Forman D, Newsham A, Morris E, Johnson O, Velikova G, Wright P
    Br J Cancer. 2011 Nov 8; 105 Suppl 1:S74-81. PMID: 22048035